Tag: bioprocessing
Cytiva expands Fast Trak™ process development and validation services facility in...
Supports multiple modalities including mAbs, pDNA/mRNA, recombinant proteins, and viral vectors
Avantor appoints Gladys Wang as Vice President, Bioprocessing Commercial, Asia, Middle...
Gladys, based in Singapore, has extensive experience collaborating with biopharma manufacturers, contract development and manufacturing organizations (CDMOs), and key opinion leaders
Merck KGaA announces €300 million investment in South Korea for new...
The new €300 million Bioprocessing Production Center in Daejeon will manufacture vaccines, cell and gene therapies, and protein-based therapies, creating 300 new jobs
Sartorius partners with Sanofi to pioneer Next-Gen Bioprocessing platform
Joint effort aims to usher in a new era of continuous downstream biomanufacturing, reducing costs and enhancing sustainability in drug production
SMART researchers pioneer novel microfluidic method to optimise bone marrow stem...
Traditional bone marrow aspirate (BMA) stem cell extraction methods are complex, time-consuming, and yield poor results due to antiquated centrifugation techniques
India’s rise to global vaccine triumph: A journey of excellence &...
India's rich history with vaccines is a testament to the country's commitment to global health
Avantor named best bioprocessing supplier in cell & gene therapy at...
Award recognizes Avantor's outstanding efforts to expand the market reach for life-altering innovative cell and gene therapies
“We expect a sea change in Indian biotech landscape”
Exclusive interaction with Aditya Sharma, Head-Bioprocessing Business, Merck Life Science India
Avantor gets Best Bioprocessing Supplier Award 2021
Company recognized for helping transform biologics production at the Asia-Pacific Bioprocessing Excellence Awards 2021...................
Avantor opens new life sciences research center
New Innovation Center in Bridgewater, New Jersey serves as a distinct center of collaboration where Avantor can provide broad contract research capabilities covering gene to protein expression, as well as final formulation and drug delivery.............